Longboard Pharmaceuticals Inc [LBPH] stock is trading at $38.90, up 13.18%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LBPH shares have gain 7.40% over the last week, with a monthly amount glided 16.92%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Longboard Pharmaceuticals Inc [NASDAQ: LBPH] stock has seen the most recent analyst activity on September 10, 2024, when Truist initiated its Buy rating and assigned the stock a price target of $60. Previously, Cantor Fitzgerald reaffirmed its Overweight rating on July 01, 2024, and elevated its price target to $90. On May 01, 2024, Robert W. Baird initiated with a Outperform rating and assigned a price target of $36 on the stock. Citigroup started tracking the stock assigning a Buy rating and suggested a price target of $40 on February 16, 2024. B. Riley Securities started tracking with a Buy rating for this stock on April 27, 2023, and assigned it a price target of $13. In a note dated April 07, 2021, Evercore ISI initiated an Outperform rating and provided a target price of $35 on this stock.
Longboard Pharmaceuticals Inc [LBPH] stock has fluctuated between $3.60 and $43.15 over the past year. Currently, Wall Street analysts expect the stock to reach $57 within the next 12 months. Longboard Pharmaceuticals Inc [NASDAQ: LBPH] shares were valued at $38.90 at the most recent close of the market. An investor can expect a potential return of 46.53% based on the average LBPH price forecast.
Analyzing the LBPH fundamentals
Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at -9113.5%, Pretax Profit Margin comes in at -8092.25%, and Net Profit Margin reading is -8092.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.37 and Total Capital is -0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.61 points at the first support level, and at 32.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 40.76, and for the 2nd resistance point, it is at 42.62.
Ratios To Look Out For
For context, Longboard Pharmaceuticals Inc’s Current Ratio is 20.95. Also, the Quick Ratio is 20.95, while the Cash Ratio stands at 0.99.
Transactions by insiders
Recent insider trading involved Kaye Randall, CMO, that happened on Sep 16 ’24 when 16666.0 shares were sold. Officer, RANDALL KAYE completed a deal on Sep 16 ’24 to buy 33333.0 shares. Meanwhile, CMO Kaye Randall bought 100.0 shares on Jan 23 ’24.
